SS

Swamy Sekhar Kaladi

Active Director Director DIN 11001981
DIN 11001981 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Swamy Sekhar Kaladi

Data last updated:

Swamy Sekhar Kaladi is a Director at Synzyme Lifesciences Private Limited (since 2025) and Director at Aavenyx Bio Sciences Private Limited (since 2025). The companies operate in Pharma and Paper.

DIN 11001981
Primary Designation Director
Industry Pharma
First Appointment 29 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synzyme Lifesciences Private Limited U21001TS2025PTC203834
Director10 Sep 20252025Active
Aavenyx Bio Sciences Private Limited U21001TS2025PTC196292
Director29 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Synzyme Lifesciences Private Limited
Aavenyx Bio Sciences Private Limited
Premium access

Shareholding and investment profile for Swamy Sekhar Kaladi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swamy Sekhar Kaladi

Swamy Sekhar Kaladi currently holds 2 directorships: Synzyme Lifesciences Private Limited (Director, since 10 Sep 2025); Aavenyx Bio Sciences Private Limited (Director, since 29 Mar 2025).

Swamy Sekhar Kaladi was first appointed on 29 Mar 2025 as Director at Aavenyx Bio Sciences Private Limited.

The current boards of Swamy Sekhar Kaladi's companies include Nishit Prakash Chandra Kadakia (Synzyme Lifesciences Private Limited), Karuna Kumari Akkirala (Aavenyx Bio Sciences Private Limited), Leela Prasad Yandrati (Aavenyx Bio Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available